Becton, Dickinson and Company Stock Wiener Boerse

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

End-of-day quote Wiener Boerse 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
218.5 EUR -0.36% Intraday chart for Becton, Dickinson and Company +0.46% -0.68%
Sales 2024 * 20.31B 18.97B Sales 2025 * 21.5B 20.09B Capitalization 67.55B 63.1B
Net income 2024 * 2.11B 1.97B Net income 2025 * 2.63B 2.45B EV / Sales 2024 * 3.96 x
Net Debt 2024 * 12.83B 11.98B Net Debt 2025 * 10.55B 9.86B EV / Sales 2025 * 3.63 x
P/E ratio 2024 *
34.1 x
P/E ratio 2025 *
28.5 x
Employees 73,000
Yield 2024 *
1.59%
Yield 2025 *
1.63%
Free-Float 77.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.36%
1 week+0.46%
Current month-4.59%
1 month-1.13%
3 months+0.69%
6 months-10.82%
Current year-0.68%
More quotes
1 week
218.50
Extreme 218.5
220.60
1 month
217.20
Extreme 217.2
229.00
Current year
214.00
Extreme 214
229.00
1 year
213.00
Extreme 213
261.00
3 years
195.20
Extreme 195.2
264.80
5 years
189.14
Extreme 189.14
264.80
10 years
189.14
Extreme 189.14
264.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 08-12-31
Director of Finance/CFO 52 21-09-05
Chief Tech/Sci/R&D Officer 48 18-12-31
Members of the board TitleAgeSince
Director/Board Member 73 02-09-23
Director/Board Member 73 13-01-28
Director/Board Member 69 10-07-25
More insiders
Date Price Change
24-04-24 218.5 -0.36%
24-04-23 219.3 -0.59%
24-04-22 220.6 +1.57%
24-04-18 217.2 -0.14%
24-04-17 217.5 -0.73%

End-of-day quote Wiener Boerse, April 23, 2024

More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
233.8 USD
Average target price
281.2 USD
Spread / Average Target
+20.27%
Consensus